Global Immune Cell Engineering Market Size & Outlook
Global immune cell engineering market, 2021-2033 (US$M)
Related Markets
Global immune cell engineering market highlights
- The global immune cell engineering market generated a revenue of USD 4,186.1 million in 2025 and is expected to reach USD 14,308.5 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 17.3% by 2033.
- In terms of segment, t cells accounted for a revenue of USD 1,930.5 million in 2025.
- NK Cells is the most lucrative cell type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, India is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 4,186.1 million |
| Market revenue in 2033 | USD 14,308.5 million |
| Growth rate | 17.3% (CAGR from 2026 to 2033) |
| Largest segment | T cells |
| Fastest growing segment | NK Cells |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | T Cells, NK Cells, Dendritic Cells, Tumor Cells, Stem Cells |
Other key industry trends
- In terms of revenue, the North America accounted for 40.2% of the global immune cell engineering market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, India is the fastest growing regional market and is projected to reach USD 880.4 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immune Cell Engineering Market Scope
Immune Cell Engineering Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lonza | View profile | - | - | - |
| Danaher Corporation | View profile | - | - | - |
| Miltenyi Biotec | View profile | 1001-5000 | Bergisch Gladbach, Nordrhein-Westfalen, Germany, Europe | http://www.miltenyibiotec.com |
| Bio-Techne Corp | View profile | 3050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | https://www.bio-techne.com |
| Takara Bio Inc | View profile | 1793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | http://www.takara-bio.co.jp |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Global immune cell engineering market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immune cell engineering market will help companies and investors design strategic landscapes.
T cells was the largest segment with a revenue share of 46.12% in 2025. Horizon Databook has segmented the Global immune cell engineering market based on t cells, nk cells, dendritic cells, tumor cells, stem cells covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Immune Cell Engineering Cell Type Outlook (Revenue, USD Million, 2021-2033)
- T Cells
- NK Cells
- Dendritic Cells
- Tumor Cells
- Stem Cells
- Others
- Global Immune Cell Engineering Product Outlook (Revenue, USD Million, 2021-2033)
- Consumables
- Instruments
- Software
- Global Immune Cell Engineering Disease Indication Outlook (Revenue, USD Million, 2021-2033)
- Cardiovascular Diseases
- Respiratory Diseases
- Infectious Diseases
- Cancer Neurological Diseases
- Others
- Global Immune Cell Engineering End Use Outlook (Revenue, USD Million, 2021-2033)
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
- Academic & Research Institutes
- Others
Reasons to subscribe to Global immune cell engineering market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global immune cell engineering market databook
-
Our clientele includes a mix of immune cell engineering market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global immune cell engineering market , including forecasts for subscribers. This global databook contains high-level insights into Global immune cell engineering market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global immune cell engineering market size, by regions, 2021-2033 (US$M)
Top 10 countries: Immune cell engineering market size, 2025 (US$M)
Global immune cell engineering market share, by cell type, 2025 & 2033 (%, US$M)
Immune cell engineering market: Opportunity assessment by country
Global immune cell engineering market, by region, 2025 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
